Agilent Technologies, Inc. (A)
Healthcare • Diagnostics & Research
StockNYSEUnited StatesUS00846U1016
171.93 USD
-0.62% today Updated 13 Nov 2026 16:24
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Agilent Technologies, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:24. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
23 Nov 2026
in 10 days · 16:00 · estimate 1.73
Last results
1.62 vs 1.49 estimated
26 Aug 2026 · Beat +9.0%
Beat the estimate
9 of 12
0 missed · 3 in line · 2 beats in a row
Average surprise
+3.4%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 23 Nov 2026 16:00 | 1.73 | — | — | Upcoming |
| 26 Aug 2026 16:00 | 1.49 | 1.62 | +9.0% | Beat |
| 27 May 2026 16:00 | 1.41 | 1.49 | +5.8% | Beat |
| 25 Feb 2026 16:00 | 1.37 | 1.36 | -0.6% | In line |
| 24 Nov 2025 16:00 | 1.58 | 1.59 | +0.4% | In line |
| 27 Aug 2025 16:00 | 1.37 | 1.37 | +0.2% | In line |
| 28 May 2025 16:00 | 1.26 | 1.31 | +3.6% | Beat |
| 26 Feb 2025 16:00 | 1.27 | 1.31 | +3.0% | Beat |
| 25 Nov 2024 16:00 | 1.41 | 1.46 | +3.9% | Beat |
| 21 Aug 2024 16:00 | 1.26 | 1.32 | +4.9% | Beat |
| 29 May 2024 16:00 | 1.19 | 1.22 | +2.4% | Beat |
| 27 Feb 2024 16:00 | 1.23 | 1.29 | +4.7% | Beat |
| 20 Nov 2023 16:00 | 1.34 | 1.38 | +3.0% | Beat |
| 15 Aug 2023 16:00 | 1.37 | 1.43 | +4.6% | Beat |
| 23 May 2023 16:00 | 1.26 | 1.27 | +0.6% | In line |
| 28 Feb 2023 16:00 | 1.31 | 1.37 | +4.5% | Beat |
| 21 Nov 2022 16:00 | 1.39 | 1.53 | +10.3% | Beat |
| 16 Aug 2022 16:00 | 1.21 | 1.34 | +11.0% | Beat |
| 24 May 2022 16:00 | 1.12 | 1.13 | +1.3% | Beat |
| 22 Feb 2022 16:00 | 1.18 | 1.21 | +2.7% | Beat |
| 22 Nov 2021 16:00 | 1.18 | 1.21 | +2.9% | Beat |
| 17 Aug 2021 16:00 | 0.99 | 1.10 | +10.6% | Beat |
| 25 May 2021 16:00 | 0.83 | 0.97 | +16.3% | Beat |
| 16 Feb 2021 16:00 | 0.90 | 1.06 | +17.7% | Beat |
| 23 Nov 2020 16:00 | 0.94 | 0.98 | +4.5% | Beat |
| 18 Aug 2020 16:00 | 0.67 | 0.78 | +16.9% | Beat |
| 21 May 2020 16:00 | 0.61 | 0.71 | +16.4% | Beat |
| 18 Feb 2020 16:00 | 0.81 | 0.81 | +0.2% | In line |
| 25 Nov 2019 16:00 | 0.86 | 0.89 | +4.0% | Beat |
| 14 Aug 2019 16:00 | 0.72 | 0.76 | +5.3% | Beat |
| 14 May 2019 16:00 | 0.72 | 0.71 | -0.9% | In line |
| 20 Feb 2019 16:00 | 0.73 | 0.76 | +3.9% | Beat |
| 19 Nov 2018 16:00 | 0.74 | 0.81 | +10.0% | Beat |
| 14 Aug 2018 16:00 | 0.63 | 0.67 | +6.5% | Beat |
| 14 May 2018 16:00 | 0.64 | 0.65 | +1.0% | Beat |
| 14 Feb 2018 16:00 | 0.58 | 0.66 | +13.2% | Beat |
| 20 Nov 2017 16:00 | 0.62 | 0.67 | +7.4% | Beat |
| 15 Aug 2017 16:00 | 0.52 | 0.59 | +12.9% | Beat |
| 22 May 2017 16:00 | 0.48 | 0.58 | +19.8% | Beat |
| 14 Feb 2017 16:00 | 0.49 | 0.53 | +8.3% | Beat |
| 15 Nov 2016 16:00 | 0.52 | 0.59 | +13.3% | Beat |
| 17 Aug 2016 16:00 | 0.47 | 0.49 | +4.8% | Beat |
| 16 May 2016 16:00 | 0.39 | 0.44 | +13.1% | Beat |
| 16 Feb 2016 16:00 | 0.43 | 0.46 | +6.4% | Beat |
| 16 Nov 2015 16:00 | 0.47 | 0.50 | +5.9% | Beat |
| 17 Aug 2015 16:00 | 0.41 | 0.44 | +8.2% | Beat |
| 18 May 2015 16:00 | 0.39 | 0.38 | -1.6% | Miss |
| 17 Feb 2015 16:00 | 0.41 | 0.41 | +0.2% | In line |
| 17 Nov 2014 16:00 | 0.89 | 0.88 | -0.8% | In line |
| 14 Aug 2014 16:00 | 0.74 | 0.78 | +5.8% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 6.9B | +6.7% | 1.3B | 18.8% | 4.57 | +3.2% | 1.2B |
| 2024 | 6.5B | -4.7% | 1.3B | 19.8% | 4.43 | +5.7% | 1.4B |
| 2023 | 6.8B | -0.2% | 1.2B | 18.1% | 4.19 | +0.2% | 1.5B |
| 2022 | 6.8B | — | 1.3B | 18.3% | 4.18 | — | 1B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 176.13 | 181.27 | 170.71 | 171.93 | -1.68% | 18,469,727 | |
| Oct 2026 | 172.00 | 182.99 | 163.32 | 174.87 | +1.49% | 46,879,500 | 0.2550 |
| Sep 2026 | 153.55 | 177.05 | 141.25 | 172.31 | +12.21% | 52,464,700 | |
| Aug 2026 | 140.29 | 163.75 | 136.66 | 153.56 | +10.98% | 43,537,300 | |
| Jul 2026 | 132.99 | 142.42 | 125.00 | 138.37 | +4.17% | 48,986,600 | |
| Jun 2026 | 133.50 | 141.09 | 123.70 | 132.83 | -1.99% | 49,943,200 | 0.2550 |
| May 2026 | 116.13 | 139.35 | 108.35 | 135.53 | +17.29% | 52,585,300 | |
| Apr 2026 | 114.01 | 124.89 | 110.31 | 115.55 | +1.38% | 38,163,400 | |
| Mar 2026 | 118.85 | 121.17 | 109.90 | 113.98 | -6.10% | 51,993,200 | 0.2550 |
| Feb 2026 | 132.63 | 137.85 | 114.49 | 121.38 | -9.32% | 48,314,600 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Capillary Electrophoresis - Global Strategic Business Report: Secure Share of the $1.1 Billion Market by 2032 as Agilent, Bio-Rad, Danaher and Thermo Fisher Accelerate CE-MS Innovation (opens in a new tab) 10 Nov 2026 15:11
- Electrophoresis Reagents - Global Strategic Business Report: Capitalize on China's 7.4% CAGR as Bio-Rad, QIAGEN, Agilent, Merck Millipore and Thermo Fisher Battle for $1.3B by 2032 (opens in a new tab) 10 Nov 2026 15:09
- Gene Panels - Global Strategic Business Report 2026: Capitalize on 17.9% CAGR as Market Triples to $12.6B by 2032 - Track Key Players Illumina, Roche, QIAGEN, Thermo Fisher, Agilent and More (opens in a new tab) 10 Nov 2026 14:24
- Agilent Expands Tumor Profiling Portfolio with SureSelect Cancer Research Pan Heme (opens in a new tab) 10 Nov 2026 13:00
- Structural Biology and Molecular Modeling Techniques - Global Strategic Business Report 2026: Capitalize on the $18 Billion 2032 Market with Agilent, Bruker Daltonics, Dassault Systemes, and Illumina (opens in a new tab) 09 Nov 2026 15:41
- Global Arrayed CRISPR Screening Market Report 2026 | Capitalize on 17.7% CAGR to $3.43 Billion as Thermo Fisher, Merck, Agilent and GenScript Advance Precision Drug Discovery (opens in a new tab) 09 Nov 2026 14:09
- Global Oligonucleotide Synthesis Services Market Report 2026 | Capitalize on $4.7B by 2030 as Thermo Fisher, Agilent, QIAGEN and IDT Accelerate GMP and CRISPR Capacity (opens in a new tab) 06 Nov 2026 14:25
- Q-TOF Mass Spectrometry - Global Strategic Business Report 2026: Capitalize on 8.9% CAGR to $1.3 Billion by 2032 as AB SCIEX, Agilent, Bruker, Thermo Fisher Scientific and Waters Battle for Share (opens in a new tab) 05 Nov 2026 15:32
- Agilent Technologies' Q4 Earnings on Deck: What's in Store for the Stock? (opens in a new tab) Zacks · 05 Nov 2026 12:55
- Here’s How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years (opens in a new tab) Benzinga · 05 Nov 2026 12:02
- Where Does Agilent Technologies (A) Value Sit After Proscia? (opens in a new tab) Simply Wall St. · 04 Nov 2026 23:23
- Microarray Analysis - Global Strategic Business Report 2026: Secure Share in a $5.1 Billion Market by 2032, Featuring Profiles of Key Players Agilent, Illumina, Roche and Thermo Fisher (opens in a new tab) 04 Nov 2026 16:31
- Life Science Instrumentation - Global Strategic Business Report 2026-2032 Featuring ACHB Enterprise, Agilent Technologies, BD, Bio-Rad Labs, Bruker Corp., ChromaCode, Danaher Corp., Emerson Electric Co., Eppendorf, GE Healthcare, Hitachi High-Tech Corp. (opens in a new tab) 04 Nov 2026 14:44
- Glycomics / Glycobiology - Global Strategic Business Report 2026: Capitalize on a $4.5 Billion Market by 2032 | Agilent, Bruker, Danaher, Merck, and Thermo Fisher Battle for Share (opens in a new tab) 04 Nov 2026 14:43
- Agilent Completes Acquisition of Proscia (opens in a new tab) 04 Nov 2026 14:12
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 173.01 USD
- Market cap
- 48.8B
- Dividend yield
- 0.59%
- 5-year average yield
- 0.68%
- Payout ratio
- 20%
- Last dividend
- 0.2550 USD · 06 Oct 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 06 Oct 2026 | 0.2550 USD |
| 30 Jun 2026 | 0.2550 USD |
| 31 Mar 2026 | 0.2550 USD |
| 06 Jan 2026 | 0.2550 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow A and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.